ZA826391B - Sulfonylureas,processes for their preparation,pharmaceutical formulations based on these compounds and their use - Google Patents
Sulfonylureas,processes for their preparation,pharmaceutical formulations based on these compounds and their useInfo
- Publication number
- ZA826391B ZA826391B ZA826391A ZA826391A ZA826391B ZA 826391 B ZA826391 B ZA 826391B ZA 826391 A ZA826391 A ZA 826391A ZA 826391 A ZA826391 A ZA 826391A ZA 826391 B ZA826391 B ZA 826391B
- Authority
- ZA
- South Africa
- Prior art keywords
- sulfonylureas
- processes
- preparation
- atoms
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813134780 DE3134780A1 (de) | 1981-09-02 | 1981-09-02 | "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA826391B true ZA826391B (en) | 1983-07-27 |
Family
ID=6140704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA826391A ZA826391B (en) | 1981-09-02 | 1982-09-01 | Sulfonylureas,processes for their preparation,pharmaceutical formulations based on these compounds and their use |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4542139A (xx) |
| EP (1) | EP0073507B1 (xx) |
| JP (1) | JPS5846068A (xx) |
| KR (1) | KR880002706B1 (xx) |
| AT (1) | ATE16102T1 (xx) |
| AU (1) | AU558339B2 (xx) |
| CA (1) | CA1193603A (xx) |
| DE (2) | DE3134780A1 (xx) |
| DK (1) | DK391982A (xx) |
| ES (6) | ES515396A0 (xx) |
| FI (1) | FI76567C (xx) |
| GR (1) | GR76895B (xx) |
| HU (1) | HU188805B (xx) |
| IL (1) | IL66697A0 (xx) |
| MX (1) | MX154808A (xx) |
| NO (1) | NO822940L (xx) |
| NZ (1) | NZ201768A (xx) |
| PH (1) | PH18218A (xx) |
| PT (1) | PT75492B (xx) |
| ZA (1) | ZA826391B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3210063A1 (de) * | 1982-03-19 | 1983-09-22 | Hoechst Ag, 6230 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
| SE9201076L (sv) * | 1992-04-06 | 1993-10-07 | Shimon Slavin | Användningen av gamla läkemedel för behandling av diabetes |
| US5681832A (en) * | 1995-02-17 | 1997-10-28 | The United States Of America As Represented By The Department Of Health And Human Services | Aroylaniline compounds, pharmaceutical compositions, and methods of using same to inhibit viral activity |
| JP2000256323A (ja) | 1999-01-08 | 2000-09-19 | Japan Tobacco Inc | ２−オキソキノリン化合物及びその医薬用途 |
| DK1357111T3 (da) * | 2000-12-28 | 2009-11-02 | Shionogi & Co | 2-pyridonderivater med affinitet for cannabinoid type 2-receptor |
| EP2428514A1 (en) * | 2005-11-03 | 2012-03-14 | Portola Pharmaceuticals, Inc. | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| CN101720324A (zh) * | 2007-05-02 | 2010-06-02 | 波托拉医药品公司 | [4-(6-氟-7-甲基氨基-2,4-二氧代-1,4-二氢-2h-喹唑啉-3-基)-苯基]-5-氯-噻吩-2-基-磺酰基脲盐、其相关的形式和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3819633A (en) * | 1970-04-01 | 1974-06-25 | Erba Carlo Spa | (iso)quinolyl sulfonylureas having antidiabetic activity |
| DE2621958A1 (de) * | 1976-05-18 | 1977-12-08 | Hoechst Ag | Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung |
| AT357560B (de) * | 1976-05-18 | 1980-07-25 | Hoechst Ag | Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen |
| MTP848B (en) * | 1978-06-27 | 1980-06-24 | Hoechst Ag | Sulfonyl ureas process for their manufacture pharmaceutical preparation on the basis of there compounds and their use |
| DE2948434A1 (de) * | 1979-12-01 | 1981-06-11 | Hoechst Ag, 6000 Frankfurt | 1-piperidinsulfonylharnstoffe und verfahren zu ihrer herstellung |
| DE2951135A1 (de) * | 1979-12-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung |
-
1981
- 1981-09-02 DE DE19813134780 patent/DE3134780A1/de not_active Withdrawn
-
1982
- 1982-08-28 EP EP82107938A patent/EP0073507B1/de not_active Expired
- 1982-08-28 AT AT82107938T patent/ATE16102T1/de not_active IP Right Cessation
- 1982-08-28 DE DE8282107938T patent/DE3266953D1/de not_active Expired
- 1982-08-31 ES ES515396A patent/ES515396A0/es active Granted
- 1982-08-31 ES ES515395A patent/ES8306114A1/es not_active Expired
- 1982-08-31 MX MX7875A patent/MX154808A/es unknown
- 1982-08-31 ES ES515397A patent/ES515397A0/es active Granted
- 1982-08-31 KR KR8203918A patent/KR880002706B1/ko active
- 1982-08-31 GR GR69173A patent/GR76895B/el unknown
- 1982-08-31 FI FI823007A patent/FI76567C/fi not_active IP Right Cessation
- 1982-08-31 NZ NZ201768A patent/NZ201768A/en unknown
- 1982-08-31 ES ES515399A patent/ES515399A0/es active Granted
- 1982-08-31 PH PH27799A patent/PH18218A/en unknown
- 1982-08-31 ES ES515384A patent/ES515384A0/es active Granted
- 1982-08-31 ES ES515398A patent/ES515398A0/es active Granted
- 1982-08-31 NO NO822940A patent/NO822940L/no unknown
- 1982-09-01 HU HU822814A patent/HU188805B/hu unknown
- 1982-09-01 PT PT75492A patent/PT75492B/pt unknown
- 1982-09-01 DK DK391982A patent/DK391982A/da not_active Application Discontinuation
- 1982-09-01 AU AU87892/82A patent/AU558339B2/en not_active Ceased
- 1982-09-01 CA CA000410586A patent/CA1193603A/en not_active Expired
- 1982-09-01 IL IL66697A patent/IL66697A0/xx unknown
- 1982-09-01 ZA ZA826391A patent/ZA826391B/xx unknown
- 1982-09-01 JP JP57150810A patent/JPS5846068A/ja active Pending
-
1984
- 1984-04-26 US US06/603,987 patent/US4542139A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0163599A3 (en) | Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents | |
| GR3018182T3 (en) | Derivatives of amidinophenylalanine, procedure for their preparation, their utilisation and anticoagulant compositions comprising them. | |
| GB8827152D0 (en) | Anti-atherosclerotic diaryl compounds | |
| ZA832292B (en) | Salicylic acid derivatives,processes for their preparation,pharmaceutical for mulations based on these compounds and their use | |
| ZA826391B (en) | Sulfonylureas,processes for their preparation,pharmaceutical formulations based on these compounds and their use | |
| ZA879280B (en) | Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds | |
| DE3369983D1 (en) | Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| ZA828639B (en) | Novel triazoloquinazolinones, their preparation and pharmaceutical formulations containing these compounds | |
| TW261605B (xx) | ||
| IL67400A0 (en) | 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them | |
| ES8402284A1 (es) | Un procedimiento para la preparacion de indoles. |